| Literature DB >> 25187486 |
Yuqi Zhou1, Wei Zhao1, Guobin Xie1, Mingfeng Huang1, Mengjie Hu1, Xin Jiang1, Dequan Zeng1, Jie Liu1, Hu Zhou2, Haifeng Chen1, Guang-Hui Wang3, Xiao-Kun Zhang4.
Abstract
Coumarins are plant-derived natural products with a broad range of known pharmacological activities including anticancer effects. However, the molecular mechanisms by which this class of promising compounds exerts their anticancer effects remain largely unknown. We report here that a furanocoumarin named apaensin could effectively induce apoptosis of cancer cells through its activation of Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK). Apoptosis induction by apaensin in cancer cells was suppressed by chemical inhibitors of JNK and p38 MAPK. Inhibition of the expression of orphan nuclear receptor Nur77 by small interfering RNA (siRNA) approach also abrogated the death effect of apaensin. Molecular analysis demonstrated that JNK activation was required for the nuclear export of Nur77, a known apoptotic event in cancer cells. Although p38 MAPK activation was not involved in Nur77 nuclear export, it was essential for Nur77 mitochondrial targeting through induction of Nur77 interaction with Bcl-2, which is also known to convert Bcl-2 from an antiapoptotic to a proapoptotic molecule. Together, our results identify a new natural product that targets orphan nuclear receptor Nur77 through its unique activation of JNK and p38 MAPK and provide insight into the complex regulation of the Nur77-Bcl-2 apoptotic pathway.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25187486 PMCID: PMC4247515 DOI: 10.1093/carcin/bgu186
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944